CHATTANOOGA – Erlanger Health System announces the Erlanger Heart and Lung Institute is participating in a clinical trial studying if blood thinners are more effective at preventing stroke in …
This item is available in full to subscribers.
If you're a print subscriber, but do not yet have an online account, click here to create one.
Click here to see your options for becoming a subscriber.
Other items that may interest you